GuangYuYuan Chinese Herbal Medicine Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Hui Miao
Chief executive officer
CN¥948.0k
Total compensation
CEO salary percentage | n/a |
CEO tenure | 2.3yrs |
CEO ownership | n/a |
Management average tenure | 4.3yrs |
Board average tenure | 1.9yrs |
Recent management updates
Recent updates
Revenues Not Telling The Story For GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHSE:600771)
Sep 25GuangYuYuan Chinese Herbal Medicine Co., Ltd.'s (SHSE:600771) Price Is Out Of Tune With Revenues
Jun 23Here's Why GuangYuYuan Chinese Herbal Medicine (SHSE:600771) Can Manage Its Debt Responsibly
May 27Getting In Cheap On GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHSE:600771) Is Unlikely
Feb 29CEO
Hui Miao (49 yo)
2.3yrs
Tenure
CN¥948,000
Compensation
Mr. Hui Miao was the Director of Shanxi Zhendong Pharmaceutical Co.,Ltd from May 22, 2020 until June 17, 2022. He serves as Director at GuangYuYuan Chinese Herbal Medicine Co., Ltd. since October 17, 2022...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President & Director | 2.3yrs | CN¥948.00k | no data | |
Secretary of the Board of Directors | 4.3yrs | CN¥480.00k | no data | |
Vice President | 4.9yrs | no data | no data |
4.3yrs
Average Tenure
50yo
Average Age
Experienced Management: 600771's management team is considered experienced (4.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President & Director | 2.2yrs | CN¥948.00k | no data | |
Director | 3yrs | no data | no data | |
Chairman | less than a year | no data | no data | |
Vice Chairman | 1.9yrs | no data | no data | |
Independent Director | 1.9yrs | CN¥96.00k | no data | |
Chairman of the Supervisory Board | 1.9yrs | no data | no data | |
Supervisor | 1.9yrs | no data | no data | |
Employee Representative Supervisor | 1.9yrs | no data | no data |
1.9yrs
Average Tenure
49.5yo
Average Age
Experienced Board: 600771's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 03:47 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
GuangYuYuan Chinese Herbal Medicine Co., Ltd. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Bin Wu | China Merchants Securities Co. Ltd. |
Min Qiu | China Merchants Securities Co. Ltd. |
Zhouyu Deng | Guosen Securities Co., Ltd. |